QuidelOrtho to Participate in Upcoming Investor Conferences
August 19 2024 - 7:00AM
Business Wire
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global
provider of innovative in vitro diagnostic technologies designed
for point-of-care settings, clinical labs and transfusion medicine,
announced today that members of its management team will attend two
upcoming investor conferences.
Morgan Stanley 22nd Annual Global Health Conference – New
York, NY
On Thursday, September 5, 2024, QuidelOrtho’s President and
Chief Executive Officer, Brian Blaser, and Chief Financial Officer,
Joseph Busky, are scheduled to participate in a fireside chat at
7:00 a.m. ET / 4:00 a.m. PT.
2024 Baird Global Healthcare Conference – New York,
NY
On Tuesday, September 10, 2024, Messrs. Blaser and Busky are
scheduled to participate in a fireside chat at 9:40 a.m. ET / 6:40
a.m. PT.
Interested parties can access the live webcasts and replays of
both events in the “Events & Presentations” section of the
“Investor Relations” page of QuidelOrtho’s website at
https://ir.quidelortho.com/.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in
vitro diagnostics, developing and manufacturing intelligent
solutions that transform data into understanding and action for
more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular
testing, clinical chemistry and transfusion medicine, bringing
fast, accurate and reliable diagnostics when and where they are
needed – from home to hospital, lab to clinic. So that patients,
clinicians and health officials can spot trends sooner, respond
quicker and chart the course ahead with accuracy and
confidence.
Building upon its many years of groundbreaking innovation,
QuidelOrtho continues to partner with customers across the
healthcare continuum and around the globe to forge a new diagnostic
frontier. One where insights and solutions know no bounds,
expertise seamlessly connects and a more informed path is
illuminated for each of us.
QuidelOrtho is advancing diagnostics to power a healthier
future.
For more information, please visit www.quidelortho.com.
Source: QuidelOrtho Corporation
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240819953266/en/
Investor Contact: Juliet Cunningham Vice President, Investor
Relations IR@QuidelOrtho.com Media Contact: D. Nikki Wheeler Senior
Director, Corporate Communications media@QuidelOrtho.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Sep 2024 to Oct 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Oct 2023 to Oct 2024